BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28677505)

  • 1. Oncostatin M: Potential Implications for Malignancy and Metabolism.
    Stephens JM; Elks CM
    Curr Pharm Des; 2017; 23(25):3645-3657. PubMed ID: 28677505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.
    Komori T; Tanaka M; Furuta H; Akamizu T; Miyajima A; Morikawa Y
    Diabetologia; 2015 Aug; 58(8):1868-76. PubMed ID: 25972231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
    Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
    J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.
    Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
    J Biol Chem; 2014 May; 289(20):13821-37. PubMed ID: 24695736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target.
    Komori T; Morikawa Y
    Anat Sci Int; 2018 Mar; 93(2):169-176. PubMed ID: 29103176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M: A mysterious cytokine in cancers.
    Masjedi A; Hajizadeh F; Beigi Dargani F; Beyzai B; Aksoun M; Hojjat-Farsangi M; Zekiy A; Jadidi-Niaragh F
    Int Immunopharmacol; 2021 Jan; 90():107158. PubMed ID: 33187910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M induces heat hypersensitivity by gp130-dependent sensitization of TRPV1 in sensory neurons.
    Langeslag M; Constantin CE; Andratsch M; Quarta S; Mair N; Kress M
    Mol Pain; 2011 Dec; 7():102. PubMed ID: 22196363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure.
    Kubin T; Gajawada P; Bramlage P; Hein S; Berge B; Cetinkaya A; Burger H; Schönburg M; Schaper W; Choi YH; Richter M
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation.
    Sanchez-Infantes D; Stephens JM
    Front Immunol; 2020; 11():612013. PubMed ID: 33854494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M is a growth factor for Ewing sarcoma.
    David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
    Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
    Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner PJ; Kastl SP; Speidl WS; Weiss TW; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1587-95. PubMed ID: 17525365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.
    Sanchez-Infantes D; White UA; Elks CM; Morrison RF; Gimble JM; Considine RV; Ferrante AW; Ravussin E; Stephens JM
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E217-25. PubMed ID: 24297795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Role for Oncostatin M in the Impairment of Glucose Homeostasis in Obesity.
    Piquer-Garcia I; Campderros L; Taxerås SD; Gavaldà-Navarro A; Pardo R; Vila M; Pellitero S; Martínez E; Tarascó J; Moreno P; Villarroya J; Cereijo R; González L; Reyes M; Rodriguez-Fernández S; Vives-Pi M; Lerin C; Elks CM; Stephens JM; Puig-Domingo M; Villarroya F; Villena JA; Sánchez-Infantes D
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e337-48. PubMed ID: 31606738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key role of suppressor of cytokine signaling 3 in regulating gp130 cytokine-induced signaling and limiting chondrocyte responses during murine inflammatory arthritis.
    Liu X; Croker BA; Campbell IK; Gauci SJ; Alexander WS; Tonkin BA; Walsh NC; Linossi EM; Nicholson SE; Lawlor KE; Wicks IP
    Arthritis Rheumatol; 2014 Sep; 66(9):2391-402. PubMed ID: 24839265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Oncostatin M Expression and Inflammatory Phenotype in Experimental Arthritis Models and Osteoarthritis Patients.
    Garcia JP; Utomo L; Rudnik-Jansen I; Du J; Zuithoff NPA; Krouwels A; van Osch GJVM; Creemers LB
    Cells; 2021 Feb; 10(3):. PubMed ID: 33673583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicity.
    Moidunny S; Matos M; Wesseling E; Banerjee S; Volsky DJ; Cunha RA; Agostinho P; Boddeke HW; Roy S
    J Neuroinflammation; 2016 Jun; 13(1):144. PubMed ID: 27287400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M: a new potent inhibitor of iodine metabolism inhibits thyroid peroxidase gene expression but not DNA synthesis in porcine thyroid cells in culture.
    Isozaki O; Tsushima T; Miyakawa M; Emoto N; Demura H; Arai M; Sato-Nozoe Y
    Thyroid; 1997 Feb; 7(1):71-7. PubMed ID: 9086575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
    Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
    Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M (OSM) protects against cardiac ischaemia/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity.
    Sun D; Li S; Wu H; Zhang M; Zhang X; Wei L; Qin X; Gao E
    J Cell Mol Med; 2015 Jun; 19(6):1296-307. PubMed ID: 25752217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.